Home › Funds › Parkside Financial Bank & Trust › ROIV

Parkside Financial Bank & Trust position in ROIV

ROIVANT SCIENCES LTD · Health Care

Parkside Financial Bank & Trust reported holding 1,329,184 shares of ROIV (ROIVANT SCIENCES LTD) in its Q3 2026 13F filing — a position valued at US$48.6M, representing 3.33% of its reported portfolio and ranking #4 among its reported holdings. Parkside Financial Bank & Trust has disclosed ROIV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.33M sh
Reported value held$48.61M
Portfolio Weight3.33%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Parkside Financial Bank & Trust's ROIV position evolved

Parkside Financial Bank & Trust first disclosed a stake in ROIV in Q3 2023 at 195 shares (US$2K). The position peaked in Q3 2026 at 1,329,184 shares, worth US$48.6M. Across 13 filings, Parkside Financial Bank & Trust increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 1,329,184 shares valued at US$48.6M. Notable position changes include a 297922% increase in Q1 2025 (shares rose 12% over the following quarter), a 113% increase in Q2 2025 (shares rose 34% over the following quarter), a 67% increase in Q4 2025 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 195 $2.28K New
Q4 2023 195 $2.19K Hold
Q1 2024 195 $2.06K Hold
Q2 2024 195 $2.06K Hold
Q3 2024 195 $2.25K Hold
Q4 2024 206 $2.44K Add
Q1 2025 613.93K $6.19M Add
Q2 2025 1.31M $14.76M Add
Q3 2025 698.52K $10.57M Reduce
Q4 2025 1.17M $25.32M Add
Q1 2026 1.33M $36.82M Add
Q2 2026 1.33M $47.04M Hold
Q3 2026 1.33M $48.61M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ROIV and 13F data

ROIV (ROIVANT SCIENCES LTD) is a Health Care company. 62 other funds we track also report a position in ROIV — the largest reported positions include QVT Financial LP (US$839.6M), Farallon Capital Management (US$506.4M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$506.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ROIV

All ROIV fund holders →

FAQ

How long has Parkside Financial Bank & Trust held ROIV?

Parkside Financial Bank & Trust has disclosed ROIV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Parkside Financial Bank & Trust's current position in ROIV?

As of Q3 2026, Parkside Financial Bank & Trust holds 1.33M shares of ROIV (ROIVANT SCIENCES LTD), valued at $48.61M, representing 3.33% of its reported portfolio and ranking #4.

Has Parkside Financial Bank & Trust been buying or selling ROIV?

In the latest 13F filing (Q3 2026), Parkside Financial Bank & Trust held unchanged its position in ROIV. The position peaked in Q3 2026 at 1.33M shares.

Which other funds hold ROIV?

Other major institutional holders of ROIV include QVT Financial LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.